Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 254
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
UK Set to Become Hub of Psychedelic Research, as British Startup...
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year...
Wesana Health Partners with University of South Carolina
Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board
Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief...
Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has...
Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production...
Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic...
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic...
Load more